Zdrowie i gospodarka · 24/09/2014

FDA Announces Draft Guidance for Veterinary Bioequivalence Studies

The Food and Drug Administration (FDA) has released a draft guidance document (GFI #224) for the veterinary industry, focusing on in vivo blood level bioequivalence studies for veterinary pharmaceutical products, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).